封面
市场调查报告书
商品编码
1927879

2026年全球生物材料市场报告

Biomaterials Global Market Report 2026

出版日期: | 出版商: The Business Research Company | 英文 250 Pages | 商品交期: 2-10个工作天内

价格
简介目录

近年来,生医材料市场发展迅速,预计2025年至2026年将以13.9%的复合年增长率从1514.7亿美元增长至1725.4亿美元。过去几年的成长可归因于整形外科和人工植牙手术的增加、心血管疾病盛行率的上升、医疗基础设施的改善、聚合物和金属加工技术的进步以及医疗植入的日益普及。

预计未来几年生医材料市场将快速成长,到2030年市场规模将达到2,844.4亿美元,复合年增长率(CAGR)为13.3%。预测期内的成长要素包括全球人口老化、再生医学需求不断增长、生医材料3D列印技术的进步、生物医学研究投资的增加以及在神经系统疾病和创伤治疗治疗领域应用范围的扩大。预测期内的主要趋势包括对生物相容性和生物活性材料的需求不断增长、可生物降解生医材料的日益普及、生医材料在组织工程中的应用日益广泛、先进植入式医疗设备的日益普及以及对定制化、患者特异性生医材料的日益关注。

医疗费用支出不断增长预计将推动生医材料市场的发展。医疗费用支出是指在特定时期内(通常指国家或机构层级)用于医疗服务、治疗和医疗基础设施的总资金。其中一部分支出用于生物材料的研究与开发、采购、实施和监管合规。例如,美国医学会 (AMA) 报告称,2023 年美国医疗保健总支出将达到 48,665 亿美元(人均 14,570 美元)。这比前一年增长了 7.5%,较 2022 年的 4.6% 增幅显着。医疗保健支出不断增长预计将推动生医材料市场的发展。

为了提供永续的生物聚合物并获得竞争优势,生医材料市场的主要企业正致力于技术创新,例如工程酶生医材料(DEB)技术平台。 DEB技术生医材料利用酵素来设计和改造材料,以应用于药物递送、组织工程和诊断等多种领域。例如,2023年6月,总部位于美国的香精香料和化妆品活性成分製造商国际香料香精公司(IFF)宣布推出其用于大规模开发生物基材料的酵素生医材料技术平台。 DEB技术旨在提供显着的永续性优势,同时提供与化石基材料相当甚至更优的性能,从而满足日益增长的环保高性能生物聚合物的需求。该技术平台使生产商能够透过取代传统的化石基合成聚合物来应对监管变化并满足不断增长的消费者需求。

目录

第一章执行摘要

第二章 市场特征

  • 市场定义和范围
  • 市场区隔
  • 主要产品和服务概述
  • 全球生物材料市场:吸引力评分及分析
  • 成长潜力分析、竞争评估、策略契合度评估、风险状况评估

第三章 市场供应链分析

  • 供应链与生态系概述
  • 主要原料、资源和供应商清单
  • 主要经销商和通路合作伙伴名单
  • 主要最终用户列表

第四章 全球市场趋势与策略

  • 关键技术和未来趋势
    • 生物技术、基因组学和精准医学
    • 永续性、气候技术和循环经济
    • 人工智慧与自主智能
    • 工业4.0和智慧製造
    • 数位化、云端运算、巨量资料和网路安全
  • 主要趋势
    • 对生物相容性和生物活性材料的需求日益增长
    • 扩大可生物降解生物材料的应用
    • 扩大生物材料在组织工程的应用
    • 先进植入式医疗设备的兴起
    • 越来越关注客製化、病患特异性生物材料

第五章 终端用户产业市场分析

  • 医院
  • 诊所
  • 门诊手术中心
  • 专业医疗中心
  • 研究和学术机构

第六章 市场:宏观经济情景,包括利率、通货膨胀、地缘政治、贸易战和关税的影响、关税战和贸易保护主义对供应链的影响,以及新冠疫情对市场的影响

第七章 全球策略分析架构、目前市场规模、市场对比及成长率分析

  • 全球生物材料市场:PESTEL 分析(政治、社会、技术、环境、法律因素、驱动因素和限制因素)
  • 全球生物材料市场规模、比较及成长率分析
  • 全球生物材料市场表现:规模与成长,2020-2025年
  • 全球生物材料市场预测:规模与成长,2025-2030年,2035年预测

第八章 全球潜在市场总量(TAM)

第九章 市场细分

  • 按类型
  • 金属生物材料、聚合物生物材料、天然生物材料、陶瓷
  • 透过使用
  • 循环系统系统、整形外科、眼科、牙科、整形外科、创伤治疗、组织工程、神经系统/中枢神经系统
  • 按最终用途
  • 医院及诊所、门诊手术中心等终端用户
  • 金属生物材料按类型细分
  • 不銹钢、钛合金、钴铬合金、镁合金
  • 按类型对聚合物基生物材料进行细分
  • 合成聚合物、天然聚合物、可生物分解聚合物
  • 天然生物材料按类型细分
  • 动物源性材料、植物来源材料
  • 陶瓷细分,依类型
  • 生物陶瓷、多孔陶瓷、非多孔陶瓷

第十章 区域与国家分析

  • 全球生物材料市场:区域表现及预测,2020-2025年、2025-2030年预测、2035年预测
  • 全球生物材料市场:依国家划分、绩效及预测(2020-2025年、2025-2030年预测、2035年预测)

第十一章 亚太市场

第十二章:中国市场

第十三章 印度市场

第十四章 日本市场

第十五章:澳洲市场

第十六章 印尼市场

第十七章 韩国市场

第十八章 台湾市场

第十九章 东南亚市场

第二十章:西欧市场

第21章英国市场

第22章 德国市场

第23章:法国市场

第24章:义大利市场

第25章:西班牙市场

第26章 东欧市场

第27章:俄罗斯市场

第28章 北美市场

第29章:美国市场

第30章:加拿大市场

第31章 南美洲市场

第32章:巴西市场

第33章 中东市场

第34章:非洲市场

第35章 市场监理与投资环境

第36章:竞争格局与公司概况

  • 生物材料市场:竞争格局及市场占有率(2024年)
  • 生物材料市场:公司估值矩阵
  • 生物材料市场:公司概况
    • Corbion NV
    • Evonik Industries AG
    • Heraeus Medical Components LLC
    • Berkeley Advanced Biomaterials Inc.
    • Zimmer Biomet Holdings Inc.

第37章:其他领先和创新企业

  • DSM Biomedical BV, PolyNovo Limited, Baxter International Inc., Stryker Corporation, Collagen Solutions plc, Invibio Ltd., Aap Implantate AG, Cam Bioceramics BV, CeramTec GmbH, CoorsTek Medical LLC, CryoLife Inc., Cerapedics Inc., Surmodics Inc., Secant Group LLC, GELITA AG

第38章 全球市场竞争基准分析与仪錶板

第39章 重大併购

第四十章:高潜力市场国家、细分市场与策略

  • 2030年生物材料市场:提供新机会的国家
  • 2030年生物材料市场:充满新机会的细分市场
  • 2030年生物材料市场:成长策略
    • 基于市场趋势的策略
    • 竞争对手策略

第41章附录

简介目录
Product Code: MM4MBIOM02_G26Q1

The biomaterials refer to manmade substances that can be utilized to support tissues or structures in the body. These are natural or synthetic materials that are used in medical applications to support, enhance, or replace damaged tissue or a biological function.

The main types of biomaterials are metallic biomaterial, polymeric biomaterials, natural biomaterials and ceramics. The metallic biomaterials are stainless steels, titanium alloys, and cobalt alloys used to provide internal support to biological tissues. The metallic biomaterials are manmade systems that are utilized in joint replacements, dental implants, orthopedic fixations, and stents to offer internal support to biological tissues. Biomaterials have a wide application in cardiovascular, orthopedic, ophthalmology, dental, plastic surgery, wound healing, tissue engineering and neurological/central nervous system and are used in hospitals and clinics, ambulatory surgical centers and other end users.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

Tariffs on specialty metals, polymers, and ceramic materials have impacted the biomaterials market by increasing raw material and manufacturing costs, particularly for metallic and polymeric biomaterials used in implants and medical devices. Regions such as North America, Europe, and Asia-Pacific are most affected due to their dependence on global supply chains for titanium alloys, polymers, and bioceramics. While tariffs have created cost pressures and pricing challenges, they have also encouraged local manufacturing, material innovation, and supply chain diversification, supporting long-term resilience in the biomaterials industry.

The biomaterials market research report is one of a series of new reports from The Business Research Company that provides biomaterials market statistics, including biomaterials industry global market size, regional shares, competitors with a biomaterials market share, detailed biomaterials market segments, market trends and opportunities, and any further data you may need to thrive in the biomaterials industry. This biomaterials market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The biomaterials market size has grown rapidly in recent years. It will grow from $151.47 billion in 2025 to $172.54 billion in 2026 at a compound annual growth rate (CAGR) of 13.9%. The growth in the historic period can be attributed to growth in orthopedic and dental implant procedures, rising prevalence of cardiovascular diseases, increased healthcare infrastructure development, advancements in polymer and metal processing technologies, growing adoption of medical implants.

The biomaterials market size is expected to see rapid growth in the next few years. It will grow to $284.44 billion in 2030 at a compound annual growth rate (CAGR) of 13.3%. The growth in the forecast period can be attributed to aging global population, increasing demand for regenerative medicine, advancements in 3d printing of biomaterials, rising investment in biomedical research, expanding applications in neurological and wound healing treatments. Major trends in the forecast period include rising demand for biocompatible and bioactive materials, growing adoption of biodegradable biomaterials, increasing use of biomaterials in tissue engineering, expansion of advanced implantable medical devices, rising focus on customized and patient-specific biomaterials.

The rising healthcare spending is expected to drive the growth of the biomaterials market. Healthcare spending refers to the total financial resources allocated for medical services, treatments, and healthcare infrastructure over a specific period, typically at a national or institutional level. A portion of this spending is directed toward the research, development, procurement, adoption, and regulatory compliance of biomaterials. For example, in 2025, according to the American Medical Association (AMA), a U.S.-based professional association, the United States spent a total of $4,866.5 billion, or $14,570 per capita, on healthcare in 2023. This represents a 7.5% increase from the previous year, reflecting a significant rise compared to the 4.6% growth seen in 2022. As healthcare spending increases, it will contribute to the growth of the biomaterials market.

Major companies operating in the biomaterials market focus on technological advancements, such as the designed enzymatic biomaterials (DEB) technology platform, to deliver sustainable biopolymers and gain a competitive advantage. The enzymatic biomaterials (DEB) technology platform involves the use of enzymes to design and modify materials for various applications, including drug delivery, tissue engineering, and diagnostics. For instance, in June 2023, International Flavors & Fragrances Inc., a US-based producer of flavors, fragrances, and cosmetic actives, launched the enzymatic biomaterials technology platform for the development of biobased materials at scale. Designed to deliver meaningful sustainability benefits with performance comparable to or superior to fossil-based materials, DEB technology helps to address growing preferences for environmentally friendly, high-performance biopolymers. The technology platform allows producers to fulfill regulatory changes and increasing consumer demand by replacing traditional fossil-based synthetic polymers.

In October 2024, RTI Surgical (RTI), a US-based medical equipment manufacturing company, acquired Collagen Solutions plc for an undisclosed amount. The objective of RTI Surgical's acquisition of Collagen Solutions is to broaden its soft tissue portfolio and improve its capabilities in the regenerative medicine sector. Collagen Solutions plc is a US-based supplier, developer, and manufacturer of medical-grade collagen, tissues, and other biomaterials for use in regenerative medicine, medical devices, and research.

Major companies operating in the biomaterials market report are Corbion N V, Evonik Industries AG, Heraeus Medical Components LLC, Berkeley Advanced Biomaterials Inc., Zimmer Biomet Holdings Inc., DSM Biomedical BV, PolyNovo Limited, Baxter International Inc., Stryker Corporation, Collagen Solutions plc, Invibio Ltd., Aap Implantate AG, Cam Bioceramics BV, CeramTec GmbH, CoorsTek Medical LLC, CryoLife Inc., Cerapedics Inc., Surmodics Inc., Secant Group LLC, GELITA AG, Kyocera Corporation, Wright Medical Group NV, KLS Martin Group GmbH & Co KG, Meccellis Biotechnology Co Ltd., Bio-on SpA, Coloplast A/S, Collagen Matrix Inc., IntrinsiQ Materials Inc., PolyActiva Pty Ltd

North America was the largest region in the biomaterials market in 2025. The regions covered in the biomaterials market are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the biomaterials market are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The biomaterials market consists of sales of metals, polymers, and composites. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Biomaterials Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses biomaterials market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
  • Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on end user analysis.
  • Benchmark performance against key competitors based on market share, innovation, and brand strength.
  • Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
  • Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for biomaterials ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The biomaterials market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
  • The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
  • The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
  • The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
  • The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
  • The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
  • Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.

Scope

  • Markets Covered:1) By Type: Metallic Biomaterial; Polymeric Biomaterials; Natural Biomaterials; Ceramics
  • 2) By Application: Cardiovascular; Orthopedic; Ophthalmology; Dental; Plastic Surgery; Wound Healing; Tissue Engineering; Neurological/Central Nervous System
  • 3) By End Use: Hospitals And Clinics; Ambulatory Surgical Centers; Other End Users
  • Subsegments:
  • 1) By Metallic Biomaterials: Stainless Steel; Titanium Alloys; Cobalt-Chromium Alloys; Magnesium Alloys
  • 2) By Polymeric Biomaterials: Synthetic Polymers; Natural Polymers; Biodegradable Polymers
  • 3) By Natural Biomaterials: Animal-Derived Materials; Plant-Derived Materials
  • 4) By Ceramics: Bioceramics; Porous Ceramics; Non-porous Ceramics
  • Companies Mentioned: Corbion N V; Evonik Industries AG; Heraeus Medical Components LLC; Berkeley Advanced Biomaterials Inc.; Zimmer Biomet Holdings Inc.; DSM Biomedical BV; PolyNovo Limited; Baxter International Inc.; Stryker Corporation; Collagen Solutions plc; Invibio Ltd.; Aap Implantate AG; Cam Bioceramics BV; CeramTec GmbH; CoorsTek Medical LLC; CryoLife Inc.; Cerapedics Inc.; Surmodics Inc.; Secant Group LLC; GELITA AG; Kyocera Corporation; Wright Medical Group NV; KLS Martin Group GmbH & Co KG; Meccellis Biotechnology Co Ltd.; Bio-on SpA; Coloplast A/S; Collagen Matrix Inc.; IntrinsiQ Materials Inc.; PolyActiva Pty Ltd
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain.
  • Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time Series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery Format: Word, PDF or Interactive Report
  • + Excel Dashboard
  • Added Benefits
  • Bi-Annual Data Update
  • Customisation
  • Expert Consultant Support

Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.

Table of Contents

1. Executive Summary

  • 1.1. Key Market Insights (2020-2035)
  • 1.2. Visual Dashboard: Market Size, Growth Rate, Hotspots
  • 1.3. Major Factors Driving the Market
  • 1.4. Top Three Trends Shaping the Market

2. Biomaterials Market Characteristics

  • 2.1. Market Definition & Scope
  • 2.2. Market Segmentations
  • 2.3. Overview of Key Products and Services
  • 2.4. Global Biomaterials Market Attractiveness Scoring And Analysis
    • 2.4.1. Overview of Market Attractiveness Framework
    • 2.4.2. Quantitative Scoring Methodology
    • 2.4.3. Factor-Wise Evaluation
  • Growth Potential Analysis, Competitive Dynamics Assessment, Strategic Fit Assessment And Risk Profile Evaluation
    • 2.4.4. Market Attractiveness Scoring and Interpretation
    • 2.4.5. Strategic Implications and Recommendations

3. Biomaterials Market Supply Chain Analysis

  • 3.1. Overview of the Supply Chain and Ecosystem
  • 3.2. List Of Key Raw Materials, Resources & Suppliers
  • 3.3. List Of Major Distributors and Channel Partners
  • 3.4. List Of Major End Users

4. Global Biomaterials Market Trends And Strategies

  • 4.1. Key Technologies & Future Trends
    • 4.1.1 Biotechnology, Genomics & Precision Medicine
    • 4.1.2 Sustainability, Climate Tech & Circular Economy
    • 4.1.3 Artificial Intelligence & Autonomous Intelligence
    • 4.1.4 Industry 4.0 & Intelligent Manufacturing
    • 4.1.5 Digitalization, Cloud, Big Data & Cybersecurity
  • 4.2. Major Trends
    • 4.2.1 Rising Demand For Biocompatible And Bioactive Materials
    • 4.2.2 Growing Adoption Of Biodegradable Biomaterials
    • 4.2.3 Increasing Use Of Biomaterials In Tissue Engineering
    • 4.2.4 Expansion Of Advanced Implantable Medical Devices
    • 4.2.5 Rising Focus On Customized And Patient-Specific Biomaterials

5. Biomaterials Market Analysis Of End Use Industries

  • 5.1 Hospitals
  • 5.2 Clinics
  • 5.3 Ambulatory Surgical Centers
  • 5.4 Specialty Medical Centers
  • 5.5 Research And Academic Institutes

6. Biomaterials Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market

7. Global Biomaterials Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis

  • 7.1. Global Biomaterials PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 7.2. Global Biomaterials Market Size, Comparisons And Growth Rate Analysis
  • 7.3. Global Biomaterials Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)
  • 7.4. Global Biomaterials Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)

8. Global Biomaterials Total Addressable Market (TAM) Analysis for the Market

  • 8.1. Definition and Scope of Total Addressable Market (TAM)
  • 8.2. Methodology and Assumptions
  • 8.3. Global Total Addressable Market (TAM) Estimation
  • 8.4. TAM vs. Current Market Size Analysis
  • 8.5. Strategic Insights and Growth Opportunities from TAM Analysis

9. Biomaterials Market Segmentation

  • 9.1. Global Biomaterials Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Metallic Biomaterial, Polymeric Biomaterials, Natural Biomaterials, Ceramics
  • 9.2. Global Biomaterials Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Cardiovascular, Orthopedic, Ophthalmology, Dental, Plastic Surgery, Wound Healing, Tissue Engineering, Neurological/Central Nervous System
  • 9.3. Global Biomaterials Market, Segmentation By End Use, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Hospitals And Clinics, Ambulatory Surgical Centers, Other End Users
  • 9.4. Global Biomaterials Market, Sub-Segmentation Of Metallic Biomaterials, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Stainless Steel, Titanium Alloys, Cobalt-Chromium Alloys, Magnesium Alloys
  • 9.5. Global Biomaterials Market, Sub-Segmentation Of Polymeric Biomaterials, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Synthetic Polymers, Natural Polymers, Biodegradable Polymers
  • 9.6. Global Biomaterials Market, Sub-Segmentation Of Natural Biomaterials, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Animal-Derived Materials, Plant-Derived Materials
  • 9.7. Global Biomaterials Market, Sub-Segmentation Of Ceramics, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Bioceramics, Porous Ceramics, Non-porous Ceramics

10. Biomaterials Market Regional And Country Analysis

  • 10.1. Global Biomaterials Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • 10.2. Global Biomaterials Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

11. Asia-Pacific Biomaterials Market

  • 11.1. Asia-Pacific Biomaterials Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 11.2. Asia-Pacific Biomaterials Market, Segmentation By Type, Segmentation By Application, Segmentation By End Use, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

12. China Biomaterials Market

  • 12.1. China Biomaterials Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 12.2. China Biomaterials Market, Segmentation By Type, Segmentation By Application, Segmentation By End Use, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

13. India Biomaterials Market

  • 13.1. India Biomaterials Market, Segmentation By Type, Segmentation By Application, Segmentation By End Use, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

14. Japan Biomaterials Market

  • 14.1. Japan Biomaterials Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 14.2. Japan Biomaterials Market, Segmentation By Type, Segmentation By Application, Segmentation By End Use, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

15. Australia Biomaterials Market

  • 15.1. Australia Biomaterials Market, Segmentation By Type, Segmentation By Application, Segmentation By End Use, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

16. Indonesia Biomaterials Market

  • 16.1. Indonesia Biomaterials Market, Segmentation By Type, Segmentation By Application, Segmentation By End Use, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

17. South Korea Biomaterials Market

  • 17.1. South Korea Biomaterials Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 17.2. South Korea Biomaterials Market, Segmentation By Type, Segmentation By Application, Segmentation By End Use, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

18. Taiwan Biomaterials Market

  • 18.1. Taiwan Biomaterials Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 18.2. Taiwan Biomaterials Market, Segmentation By Type, Segmentation By Application, Segmentation By End Use, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

19. South East Asia Biomaterials Market

  • 19.1. South East Asia Biomaterials Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 19.2. South East Asia Biomaterials Market, Segmentation By Type, Segmentation By Application, Segmentation By End Use, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

20. Western Europe Biomaterials Market

  • 20.1. Western Europe Biomaterials Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 20.2. Western Europe Biomaterials Market, Segmentation By Type, Segmentation By Application, Segmentation By End Use, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

21. UK Biomaterials Market

  • 21.1. UK Biomaterials Market, Segmentation By Type, Segmentation By Application, Segmentation By End Use, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

22. Germany Biomaterials Market

  • 22.1. Germany Biomaterials Market, Segmentation By Type, Segmentation By Application, Segmentation By End Use, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

23. France Biomaterials Market

  • 23.1. France Biomaterials Market, Segmentation By Type, Segmentation By Application, Segmentation By End Use, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

24. Italy Biomaterials Market

  • 24.1. Italy Biomaterials Market, Segmentation By Type, Segmentation By Application, Segmentation By End Use, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

25. Spain Biomaterials Market

  • 25.1. Spain Biomaterials Market, Segmentation By Type, Segmentation By Application, Segmentation By End Use, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

26. Eastern Europe Biomaterials Market

  • 26.1. Eastern Europe Biomaterials Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 26.2. Eastern Europe Biomaterials Market, Segmentation By Type, Segmentation By Application, Segmentation By End Use, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

27. Russia Biomaterials Market

  • 27.1. Russia Biomaterials Market, Segmentation By Type, Segmentation By Application, Segmentation By End Use, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

28. North America Biomaterials Market

  • 28.1. North America Biomaterials Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 28.2. North America Biomaterials Market, Segmentation By Type, Segmentation By Application, Segmentation By End Use, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

29. USA Biomaterials Market

  • 29.1. USA Biomaterials Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 29.2. USA Biomaterials Market, Segmentation By Type, Segmentation By Application, Segmentation By End Use, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

30. Canada Biomaterials Market

  • 30.1. Canada Biomaterials Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 30.2. Canada Biomaterials Market, Segmentation By Type, Segmentation By Application, Segmentation By End Use, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

31. South America Biomaterials Market

  • 31.1. South America Biomaterials Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 31.2. South America Biomaterials Market, Segmentation By Type, Segmentation By Application, Segmentation By End Use, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

32. Brazil Biomaterials Market

  • 32.1. Brazil Biomaterials Market, Segmentation By Type, Segmentation By Application, Segmentation By End Use, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

33. Middle East Biomaterials Market

  • 33.1. Middle East Biomaterials Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 33.2. Middle East Biomaterials Market, Segmentation By Type, Segmentation By Application, Segmentation By End Use, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

34. Africa Biomaterials Market

  • 34.1. Africa Biomaterials Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 34.2. Africa Biomaterials Market, Segmentation By Type, Segmentation By Application, Segmentation By End Use, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

35. Biomaterials Market Regulatory and Investment Landscape

36. Biomaterials Market Competitive Landscape And Company Profiles

  • 36.1. Biomaterials Market Competitive Landscape And Market Share 2024
    • 36.1.1. Top 10 Companies (Ranked by revenue/share)
  • 36.2. Biomaterials Market - Company Scoring Matrix
    • 36.2.1. Market Revenues
    • 36.2.2. Product Innovation Score
    • 36.2.3. Brand Recognition
  • 36.3. Biomaterials Market Company Profiles
    • 36.3.1. Corbion N V Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.2. Evonik Industries AG Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.3. Heraeus Medical Components LLC Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.4. Berkeley Advanced Biomaterials Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.5. Zimmer Biomet Holdings Inc. Overview, Products and Services, Strategy and Financial Analysis

37. Biomaterials Market Other Major And Innovative Companies

  • DSM Biomedical BV, PolyNovo Limited, Baxter International Inc., Stryker Corporation, Collagen Solutions plc, Invibio Ltd., Aap Implantate AG, Cam Bioceramics BV, CeramTec GmbH, CoorsTek Medical LLC, CryoLife Inc., Cerapedics Inc., Surmodics Inc., Secant Group LLC, GELITA AG

38. Global Biomaterials Market Competitive Benchmarking And Dashboard

39. Key Mergers And Acquisitions In The Biomaterials Market

40. Biomaterials Market High Potential Countries, Segments and Strategies

  • 40.1 Biomaterials Market In 2030 - Countries Offering Most New Opportunities
  • 40.2 Biomaterials Market In 2030 - Segments Offering Most New Opportunities
  • 40.3 Biomaterials Market In 2030 - Growth Strategies
    • 40.3.1 Market Trend Based Strategies
    • 40.3.2 Competitor Strategies

41. Appendix

  • 41.1. Abbreviations
  • 41.2. Currencies
  • 41.3. Historic And Forecast Inflation Rates
  • 41.4. Research Inquiries
  • 41.5. The Business Research Company
  • 41.6. Copyright And Disclaimer